e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease
Montani D., Achouh L., Marcelin A. G., Viard J-P., Hermine O., Canioni D., Sitbon O., Simonneau G., Humbert M.
Source:
Eur Respir J 2005; 26: 969-972
Journal Issue:
November
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Montani D., Achouh L., Marcelin A. G., Viard J-P., Hermine O., Canioni D., Sitbon O., Simonneau G., Humbert M.. Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease. Eur Respir J 2005; 26: 969-972
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009
Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012
Reversible pulmonary hypertension associated with multivisceral Whipple's disease
Source: Eur Respir J, 57 (2) 2003132; 10.1183/13993003.03132-2020
Year: 2021
Pulmonary involvement in behcet's disease
Source: Eur Respir J 2002; 20: Suppl. 38, 63s
Year: 2002
Pulmonary hypertension associated with Whipple disease
Source: Eur Respir Rev 2014; 23: 533-536
Year: 2014
Pulmonary arterial hypertension associated with congenital heart disease
Source: Eur Respir Rev 2012 21: 328-337
Year: 2012
Pulmonary arterial hypertension masquerading as severe refractory asthma
Source: Eur Respir J 2008; 32: 513-516
Year: 2008
Pulmonary arterial hypertension: an autoimmune disease?
Source: Eur Respir J 2005; 26: 986-988
Year: 2005
Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Pulmonary veno-occlusive disease
Source: Eur Respir J 2016; 47:1518-1534
Year: 2016
Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007
Pulmonary veno-occlusive disease and pulmonary capillary haemangiomatosis
Source: Eur Respir Mon 2012; 57: 182-193
Year: 2012
Changing demographics of pulmonary arterial hypertension in congenital heart disease
Source: Eur Respir Rev 2010 19: 308-313
Year: 2010
Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
Vascular, pulmonary and cardiac involvement in Behcet’s disease
Source: Eur Respir J 2004; 24: Suppl. 48, 279s
Year: 2004
IgG4-related disease in pulmonary arterial hypertension on long-term epoprostenol treatment
Source: Eur Respir J 2014; 43: 1516-1519
Year: 2014
Pulmonary hypertension and pulmonary vascular disease: course report
Source: Breathe, 14 (1) e4; 10.1183/20734735.019917
Year: 2018
Pulmonary hypertension due to lung disease
Source: International Congress 2017 – Russian Programme 2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept